<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29378</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of ultrasound dopplerography with an acutecaptopril test in assessing renal hemodynamics in chronicglomerulonephritis</article-title><trans-title-group xml:lang="ru"><trans-title>РОЛЬ УЛЬТРАЗВУКОВОЙ ДОППЛЕРОГРАФИИ С ИСПОЛЬЗОВАНИЕМ ОСТРОЙФАРМАКОЛОГИЧЕСКОЙ ПРОБЫ С КАПТОПРИЛОМ В ОЦЕНКЕ ПОЧЕЧНОЙГЕМОДИНАМИКИ ПРИ ХРОНИЧЕСКОМ ГЛОМЕРУЛОНЕФРИТЕ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Marlynov</surname><given-names>S A</given-names></name><name xml:lang="ru"><surname>Мартынов</surname><given-names>С А</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shvetsov</surname><given-names>M Yu</given-names></name><name xml:lang="ru"><surname>Швецов</surname><given-names>М Ю</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kutyrina</surname><given-names>I M</given-names></name><name xml:lang="ru"><surname>Кутырина</surname><given-names>И М</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Miroshnichenko</surname><given-names>N G</given-names></name><name xml:lang="ru"><surname>Мирошниченко</surname><given-names>П Г</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kushnir</surname><given-names>V V</given-names></name><name xml:lang="ru"><surname>Кушнир</surname><given-names>В В</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Petrov</surname><given-names>S V</given-names></name><name xml:lang="ru"><surname>Петров</surname><given-names>С В</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Struchkova</surname><given-names>T Ya</given-names></name><name xml:lang="ru"><surname>Стручкова</surname><given-names>Т Я</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dzhanaliev</surname><given-names>B R</given-names></name><name xml:lang="ru"><surname>Джаналиев</surname><given-names>Б Р</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varshavsky</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Варшавский</surname><given-names>В А</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Proskurneva</surname><given-names>E P</given-names></name><name xml:lang="ru"><surname>Проскурнева</surname><given-names>Е П</given-names></name></name-alternatives><bio xml:lang="ru"><p>ММ А им. И. М. Сеченова</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ММ А им. И. М. Сеченова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2003-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2003</year></pub-date><volume>78</volume><issue>6</issue><issue-title xml:lang="en">NO6 (2003)</issue-title><issue-title xml:lang="ru">ТОМ 78, №6 (2003)</issue-title><fpage>41</fpage><lpage>46</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2003, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2003, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2003</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/29378">https://ter-arkhiv.ru/0040-3660/article/view/29378</self-uri><abstract xml:lang="ru"><p>Aim. To examine blood flow in renal and intrarenal arteries and its changes in the acute pharmacological test with captopril in patients with chronic glomerulonephritis (CGN).
Material and methods. Renal circulation was studied in 50 patients with CGN using ultrasound dopplerography (USDG) of renal vessels on the unit GE Logiq 400 CL PRO Series. The velocity and indices of peripheral blood resistance in the major renal artery (RA) and in intrarenal arteries were estimated. In 26 patients the blood flow was studied again after intake of 50 mg captopril.
Results. Poor renal blood flow was registered in cortical parenchyma in 36% CGN patients (with
chronic renal failure in 75%). Multifactorial regression analysis has demonstrated that only blood creatinine was independently related with slowing down of the blood flow at the level of RA and intrarenal arteries. Morphological index of activity correlated with resistance indices while a high sclerosis
index correlated with blood flow slowing. Older patients had higher resistance indices. Captopril significantly accelerated Mod flow and insignificantly changed indices of peripheral resistance including
those in CRF patients.
Conclusion. Poor blood flow in the cortical layer of renal parenchyma in CGN, according to USDG,
occurs rather frequently and was associated with CRF and older age of the patients. Blocking of reninangiotensin system at the level of angiotensin II formation improves renal blood flow in most of the patients.</p></abstract><kwd-group xml:lang="en"><kwd>chronic glomerulonephritis</kwd><kwd>chronic renal failure</kwd><kwd>dopplerography</kwd><kwd>renal hemodynamics</kwd><kwd>inhibitors of angiotensin-converting enzyme</kwd><kwd>captopril</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Mackenzie H. S., Brenner В. М. Current strategies for retarding progression of renal disease. Am. J. Kidney Dis. 1998; 31: 161-170.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Тареева И. Е., Кутырина И. М., Николаев А. Ю. и др. Пути торможения развития хронической почечной недостаточности. Тер. арх. 2000; 6: 9-14.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wolf G. Angiotensin II: a pivotal factor in the progression of renal diseases. Nephrol. Dial. Transplant. 1999; 14 (suppl. 1): 42-44.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Distler A., Spies K.-S. Diagnostic procedure in renovascular hypertension. Clin. Nephrol. 1991; 36: 174-180.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Burdick L., Arioldi F., Marana I. et al. Superiority of acceleration time over pulsatility and resistance indices as screening tests for renal artery stenosis. J. Hypertens. 1996; 14:1229- 1235.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Johansson M., Jensen G., Aurell M. et al. Evaluation of duplex ultrasound and captopril renography for detection of renovascular hypertension. Kidney Int. 2000; 58: 774-782.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Radermacher J., Brunkhorst R. Diagnosis and treatment of renovascular stenosis - a cost - benefit analysis. Nephrol. Dial. Transplant. 1998; 13:2761-2767.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Coen G., Manni M., Giannoni M. F. Ischemic nephropathy in an elderly nephrologic and hypertensive population. Am. J. Nephrol. 1998; 18: 221-227.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Rene P. C., Oliva V. L., Bui В. Т. Renal artery stenosis: evaluation of Doppler US after inhibition of angiotensin-converting enzyme with captopril. Radiology 1995; 196: 675-679.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ходарева Е. Н., Сергиенко И. В. Значение радионуклидных методов исследования у больных реноваскулярной гипертонией. Визуализ. в клинике 1998; 6: 39-47.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Djerassi R., Bogov В., Ljubomirova M. et al. What's new in the diagnostic algorithm in patients with chronic renal failure (CRF): conventional ultrasound Doppler wave analysis. In: Abstracts. XXXVI Congress of the ERA-EDTA. Madrid. 1999. 153.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Petrichko M., Glazun L., Polukhina E. et al. Doppler evaluation of chronic renal failure progression in patients with chronic glomerulonephritis. Nephrol. Dial. Transplant. 2002; 17 (abstr. suppl. 1): 233-234.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Matsumoto N., lshimura E., Taniwaki H. et al. Intrarenal hemodynamic abnormalities in no-dialyzed patients with chronic renal failure (CRF) measured by duplex Doppler sonography. In: Abstracts. XXXVI Congress of the ERA-EDTA. 1999. 173.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Petersen L. J., Petersen J. R., Talleruthuus U. et al. The pulsatility index and the resistance index in renal arteries. Associations with long-term progression in chronic renal failure. Nephrol. Dial. Transplant. 1997; 12: 1376-1380.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Бугрова О. В., Кутырина И. М., Багирова В. В. и др. Влияние острой фармакологической блокады ренин-ангиотензиновой системы на внутрипочечную гемодинамику \ больных системной красной волчанкой и системной склеродермией. Тер. арх. 2001; 6: 20-25.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Meyrier A., Hill G. S., Simon P. Ischemic renal diseases: New insights into old entities. Kidney Int. 1998; 54: 2-13.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>London G., Marchais S. J., Giterin A. P. et al Arterial structure and function in end-stage renal disease. Nephrol. Dial. Transplant. 2002; 17: 1713-1724.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Luke R. G. Hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is a important cause of endstage renal disease. Ibid. 1999; 14: 2271-2278.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Klahr S. The role of nitric oxide in hypertension and renal disease progression. Ibid. 2001; 16 (suppl. 1): 60-62.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Есаян А. М., Каюков И. Г., Титова В. А. Влияние ингибитора ангиотензинпревращающего фермента эналаприла на темпы прогрессирования хронической почечной недостаточности у больных с нарушениями функционального состояния почек различной степени. Тер. арх. 1995; 5: 57- 59.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Кутырина И. М., Тареева И. Е., Герасименко О. И. и др. Использование ингибиторов ангиотензинпревращающего фермента при хронических диффузных заболеваниях почек. Там же. 6: 20-23.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Швецов М. Ю. Блокаторы рецепторов ангиотензина II - первый опыт и перспективы применения в нефрологии. Там же. 2000; 6: 73-79.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Кутырина И. М., Лифишц Н. Л., Рогов В. А и др. Применение ингибиторов ангиотензинпревращающего фермента при хронической почечной недостаточности. Там же. 2002; 6: 34-39.</mixed-citation></ref></ref-list></back></article>
